NDC 73309-207 - Ondansetron HCl dihydrate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 73309-207
- Package NDCs from labels
- 73309-207-01, 73309-207-02
- Manufacturer
- BLUEBAY SHANDONG CO.,LTD
- Effective date
- 2021-10-21
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Ondansetron HCl dihydrate - BLUEBAY SHANDONG CO.,LTD | BLUEBAY SHANDONG CO.,LTD | 2021-10-21 | BULK INGREDIENT |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 73309-207-01 | Ondansetron HCl dihydrate | 250 g in 1 JAR | POWDER | 250 | 2 | |
| 73309-207-02 | Ondansetron HCl dihydrate | 25 g in 1 JAR | POWDER | 25 | 2 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ondansetron | ONDANSETRON HYDROCHLORIDE | Atlantic Biologics Corp. | 41d71d26-0d42-b368-e063-6394a90add43 | 2025-10-23 | Warnings, Adverse reactions | NMH84OZK2B |
| Ondansetron | ONDANSETRON | Cardinal Health 107, LLC | 61758670-91ab-4422-8d9d-e8ca87eecae8 | 2025-10-23 | Warnings, Adverse reactions | NMH84OZK2B |
| Ondansetron | ONDANSETRON | Amneal Pharmaceuticals LLC | 38435346-d505-4bdd-bbc6-a7bcba411033 | 2025-09-23 | Warnings, Adverse reactions | NMH84OZK2B |
| Ondansetron Hydrochloride | ONDANSETRON HYDROCHLORIDE | PHOENIX RX LLC | 3a79fc2b-9ea3-a808-e063-6394a90ae794 | 2025-09-22 | Warnings, Adverse reactions | NMH84OZK2B |
| Ondansetron Hydrochloride | ONDANSETRON HYDROCHLORIDE | PHOENIX RX LLC | 40106070-6a25-5b0e-e063-6394a90a4197 | 2025-09-22 | Warnings, Adverse reactions | NMH84OZK2B |
| Ondansetron | ONDANSETRON | Fosun Pharma USA Inc. | e3f22b7e-b6ad-4799-93c7-d30540cada85 | 2025-09-19 | Warnings, Adverse reactions | NMH84OZK2B |
| Ondansetron Hydrochloride | ONDANSETRON HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 0b675b09-fe40-435c-b91a-c61cdf767fbf | 2025-09-15 | Warnings, Adverse reactions | NMH84OZK2B |
| Ondansetron Hydrochloride | ONDANSETRON HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | 36d64400-2d13-4a1a-a1ca-4741cd3d3f1a | 2025-09-03 | Warnings, Adverse reactions | NMH84OZK2B |
| Ondansetron | ONDANSETRON | NorthStar Rx LLC | 9d5e7650-95be-4b96-b29c-374f673eb7a1 | 2025-09-03 | Warnings, Adverse reactions | NMH84OZK2B |
| Ondansetron Hydrochloride | ONDANSETRON HYDROCHLORIDE | Rising Pharma Holdings, Inc. | 90e0e508-75f7-4c8b-bb38-898aa4c531c3 | 2025-09-01 | Warnings, Adverse reactions | NMH84OZK2B |
| ONDANSETRON | ONDANSETRON | ProPharma Distribution | 3d5d25eb-8711-ef8c-e063-6394a90a5e03 | 2025-08-27 | Warnings, Adverse reactions | NMH84OZK2B |
| ONDANSETRON | ONDANSETRON | Apotex Corp. | 2c68d202-fdf7-4b6a-dd7f-82624fcdbd4a | 2025-08-26 | Warnings, Adverse reactions | NMH84OZK2B |
| Ondansetron Hydrochloride | ONDANSETRON HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 426ba54f-199a-41d1-8c27-f827bea56854 | 2025-08-15 | Warnings, Adverse reactions | NMH84OZK2B |
| Ondansetron | ONDANSETRON HYDROCHLORIDE | NorthStar Rx LLC | ac3dfb81-a4c7-4147-9374-c234153b7c51 | 2025-08-11 | Warnings, Adverse reactions | NMH84OZK2B |
| Ondansetron | ONDANSETRON | Gland Pharma Limited | 35716914-ac73-43c0-9aa0-09c99211d941 | 2025-07-31 | Warnings, Adverse reactions | NMH84OZK2B |
| Ondansetron | ONDANSETRON | Gland Pharma Limited | 3efa5604-96c3-42a0-8e99-b3de4a66aa92 | 2025-07-31 | Warnings, Adverse reactions | NMH84OZK2B |
| Ondansetron Hydrochloride | ONDANSETRON HYDROCHLORIDE | PHOENIX RX LLC | 3a76bae2-04c2-ee2d-e063-6394a90ad4c8 | 2025-07-21 | Warnings, Adverse reactions | NMH84OZK2B |
| Ondansetron Hydrochloride | ONDANSETRON HYDROCHLORIDE | Aurobindo Pharma Limited | 57578387-1918-4e56-a564-f14fb22340bf | 2025-07-19 | Warnings, Adverse reactions | NMH84OZK2B |
| Ondansetron | ONDANSETRON HYDROCHLORIDE | Aurobindo Pharma Limited | cf10d256-dd89-4a91-a3ed-81db505a79c2 | 2025-07-08 | Warnings, Adverse reactions | NMH84OZK2B |
| ONDANSETRON | ONDANSETRON HYDROCHLORIDE | Dr. Reddy's Laboratories Limited | 162f2088-9fb1-47e7-b88c-45104be7e7bb | 2025-06-30 | Warnings, Adverse reactions | NMH84OZK2B |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.